RanaRamziMcKayMD

Oncology • La Jolla, CA

Physician

Join to view full profile

Dr. McKay is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. McKay's full profile

Already have an account?

Office
3855 Health Sciences Drive #0987
La Jolla, CA 92093
Phone+1 858-822-6185
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
Johns Hopkins UniversityResidency, Internal Medicine, 2008 - 2011
University of Florida College of MedicineClass of 2008

Certifications & Licensure

CA State Medical License 2016 - 2024
MA State Medical License 2011 - 2018

Clinical Trials

Study CB-839 in Combination With Nivolumab in Patients With Melanoma, Clear Cell Renal Cell Carcinoma (ccRCC) and Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2016 Aug 01
Terminated
Phase 1, Phase 2
International Registry for Men With Advanced Prostate Cancer (IRONMAN) Start of enrollment: 2017 Jul 21
Recruiting
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis Start of enrollment: 2019 Feb 04
Suspended
Phase 1, Phase 2
A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer Start of enrollment: 2018 Nov 26
Active, not recruiting
Phase 2, Phase 3
Testing the Addition of a New Anti-cancer Drug, Radium-223 Dichloride, to the Usual Treatment (Cabozantinib) for Advanced Renal Cell Cancer That Has Spread to the Bone, the RadiCaL Study Start of enrollment: 2020 Jul 29
Recruiting
Phase 2
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors Start of enrollment: 2017 Dec 28
Active, not recruiting
Phase 2
Roles: Contact, Principal Investigator
Improving Germline Testing in At-Risk Patients With Prostate Cancer Start of enrollment: 2022 Sep 27
Recruiting
Not Applicable
Roles: Principal Investigator, Contact
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterations Start of enrollment: 2023 Feb 01
Recruiting
Phase 2
Roles: Contact, Sponsor-Investigator, Principal Investigator
Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2023 Feb 02
Recruiting
Phase 2
Roles: Sponsor-Investigator, Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Correction: Robustness of cancer microbiome signals over a broad range of methodological variation.
Gregory D Sepich-Poore, Daniel McDonald, Evguenia Kopylova, Caitlin Guccione, Qiyun Zhu, George Austin, Carolina Carpenter, Serena Fraraccio, Stephen Wandro, Tomasz Ko...> ;Oncogene. 2024 Apr 5
Impact of renal cell carcinoma molecular subtypes on immunotherapy and targeted therapy outcomes.
Renée Maria Saliby, Chris Labaki, Tejas R Jammihal, Wanling Xie, Maxine Sun, Valisha Shah, Eddy Saad, M Harry Kane, Soki Kashima, Katherine Sadak, Talal El Zarif, Deep...> ;Cancer Cell. 2024 Apr 4
First-line combination treatment with PARP and androgen receptor-signaling inhibitors in HRR-deficient mCRPC: Applying clinical study findings to clinical practice in ...
Rana R McKay, Alicia K Morgans, Neal D Shore, Curtis Dunshee, Geeta Devgan, Neeraj Agarwal> ;Cancer Treatment Reviews. 2024 May 1
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers.
Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik El-Deiry, Emmanuel S Antonarakis, Stephanie L Graff, Michael J Hall, Hossein Bo...> ;Nature Cancer. 2024 Mar 25
Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes.
Amin H Nassar, Talal El Zarif, Ahmed Bilal Khalid, Serena Rahme, Caiwei Zhong, Lucia Kwak, Marita Salame, Elias Bou Farhat, Dory Freeman, Edward El-Am, Arjun Ravishank...> ;Journal for Immunotherapy of Cancer. 2024 Mar 5
1 citations
Adrenal-Permissive Germline HSD3B1 Allele and Prostate Cancer Outcomes.
Tyler J Nelson, Meghana S Pagadala, Craig C Teerlink, Anthony Gao, Fatai Y Agiri, Reid F Thompson, Kathryn M Pridgen, Tyler M Seibert, Kyung Min Lee, Hannah Carter, Ju...> ;JAMA Network Open. 2024 Mar 4
The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma.
Priyanka Naik, Harshitha Dudipala, Yu-Wei Chen, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Therapeutic Advances in Urology. 2024 Feb 29
Robustness of cancer microbiome signals over a broad range of methodological variation.
Gregory D Sepich-Poore, Daniel McDonald, Evguenia Kopylova, Caitlin Guccione, Qiyun Zhu, George Austin, Carolina Carpenter, Serena Fraraccio, Stephen Wandro, Tomasz Ko...> ;Oncogene. 2024 Apr 1
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Dian...> ;Cancer. 2024 Feb 20
1 citations
Clinical Outcomes Among Immunotherapy-Treated Patients With Primary Cardiac Soft Tissue Sarcomas: A Multicenter Retrospective Study.
Amin H Nassar, Edward El-Am, Ryan Denu, Sarah Abou Alaiwi, Talal El Zarif, Walid Macaron, Noha Abdel-Wahab, Aakash Desai, Caleb Smith, Kaushal Parikh, Muhannad Abbasi,...> ;JACC. Cardiooncology. 2024 Feb 1
1 citations
Outcomes of Patients with Brain Metastases from Renal Cell Carcinoma Receiving First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Dat...
Kosuke Takemura, Audreylie Lemelin, Matthew S Ernst, J Connor Wells, Renee Maria Saliby, Talal El Zarif, Chris Labaki, Naveen S Basappa, Bernadett Szabados, Thomas Pow...> ;European Urology. 2024 Jan 29
Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States.
Rencsok, E., Slopen, N., McManus, H., Autio, K., Morgans, A., McSwain, L., Barata, P., Cheng, H., Dreicer, R., Gerke, T., Green, R., Heath, E., Howard, L., McKay, R., ...> ;Cancer Research Communications. 2024 Jan 8
Treatment Landscape of Renal Cell Carcinoma.
Yu-Wei Chen, Luke Wang, Justine Panian, Sohail Dhanji, Ithaar Derweesh, Brent Rose, Aditya Bagrodia, Rana R McKay> ;Current Treatment Options in Oncology. 2023 Dec 1
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel...> ;Future Oncology. 2024 Mar 1
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Channing J Paller, Pedro C Barata, Justin Lorentz, Leonard J Appleman, Andrew J Armstrong, Tiffani A DeMarco, Robert Dreicer, Jo Ann B Elrod, Mark Fleming, Christopher...> ;The Prostate. 2024 Feb 1
Characterization of Patients with Metastatic Renal Cell Carcinoma Undergoing Deferred, Upfront, or No Cytoreductive Nephrectomy in the Era of Combination Immunotherapy...
Kosuke Takemura, Matthew S Ernst, Vishal Navani, J Connor Wells, Ziad Bakouny, Frede Donskov, Naveen S Basappa, Lori A Wood, Luis Meza, Sumanta K Pal, Bernadett Szabad...> ;European Urology Oncology. 2023 Oct 30
Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, Jared D Acoba, Joy Awosika, Ziad Bakouny, Nicole B Balmaceda, Ting ...> ;Elife. 2023 Oct 17
1 citations
Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Vikas, P., Shuchi Gulati, Chih-Yuan Hsu, Surbhi Shah, Pankil K Shah, Rebecca Zon, Susan Alsamarai, Joy Awosika, Ziad El-Bakouny, Babar Bashir, Alicia Beeghly, Stephani...> ;JAMA Oncology. 2023 Oct 1
8 citations
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Bassel Nazha, Tony Zhuang, Sharon Wu, Jacqueline T Brown, Daniel Magee, Bradley C Carthon, Omer Kucuk, Chadi Nabhan, Pedro C Barata, Elisabeth I Heath, Charles J Ryan,...> ;Cancer. 2023 Dec 15
7 citations
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in Pe...
Dobbs, R. W., Talal El Zarif, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, Taylor Nonato, Rana R McKay, Mingji...> ;Journal of Clinical Oncology. 2023 Jul 20
1 citations
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Emily M Rencsok, Natalie Slopen, Karen Autio, Alicia Morgans, Lawrence McSwain, Pedro Barata, Heather H Cheng, Robert Dreicer, Elisabeth Heath, Rana R McKay, Mark Pome...> ;Quality of Life Research. 2023 Nov 1
12 citations
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal ...
Ernst, M., Navani, V., Wells, J., Donskov, F., Basappa, N., Labaki, C., Pal, S., Meza, L., Wood, L., Ernst, D., Szabados, B., McKay, R., Parnis, F., Suarez, C., Yuasa,...> ;European Urology. 2023 Jul 1
2 citations
Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.
Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin, Dimitrios Makrakis, Leonidas N Diamantopoulos, Nishita Tripathi, Neeraj Agarwal, Roubini Zakopoulou, A...> ;Clinical Genitourinary Cancer. 2023 Oct 1
5 citations
Metastatic renal cell carcinoma to the pancreas and other sites-a multicenter retrospective study.
Cassandra Duarte, Junxiao Hu, Benoit Beuselinck, Justine Panian, Nicole Weise, Nazli Dizman, Katharine A Collier, Nityam Rathi, Haoran Li, Roy Elias, Nieves Martinez-C...> ;Eclinicalmedicine. 2023 Jun 1
New drug approvals in prostate cancer and their effect on the treatment landscape.
Chinmay Jani, Nour Abdallah, Pavlina Chrysafi, Christian Mouchati, Daniel Herchenhorn, Rana R McKay> ;Clinical Advances in Hematology & Oncology. 2023 Jun 1
Join now to see all

Journal Articles

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell Carcinoma
Praful Ravi, Charlene Mantia, Christopher Su, Neeraj Agarwal, Yousef Zakharia, Rana R Mckay, Vivek Narayan, Ajjai Alva, Bradley A Mcgregor, David F Mcdermott, Toni K C..., JAMA Oncology

Authored Content

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020
Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients with Renal Cell CarcinomaMay 2020

Press Mentions

NCCN Clinical Practice Guidelines in Oncology: 2023 UpdatesMay 19th, 2023
Adaptive Nivolumab plus Ipilimumab Improves Outcomes in mRCCOctober 7th, 2022
Patient First in Region to Receive New Treatment for Advanced Prostate CancerOctober 5th, 2022
Join now to see all